Effect of isatin on nitric oxide-stimulated soluble guanylate cyclase from human platelets

Biochem Pharmacol. 2002 Feb 15;63(4):763-6. doi: 10.1016/s0006-2952(01)00809-7.

Abstract

Isatin, an endogenous indole, has previously been shown to inhibit atrial natriuretic peptide (ANP)-stimulated particulate guanylate cyclase activity. Here, it was shown that it can be transported to human platelets where it inhibited nitric oxide (NO)-stimulated soluble guanylate cyclase activity obtained from human platelets. The effect was most pronounced at 10(-8)M isatin and is the most potent effect of isatin yet observed. The dose response curve was bell shaped with higher doses becoming less effective. The maximal inhibition observed was of 40%. Isatin had no effect on protoporphyrin IX-stimulated guanylate cyclase. Isatin-dependent regulation of ligand-stimulated guanylate cyclases is suggested to promote a stress-induced switch in metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Platelets / drug effects*
  • Blood Platelets / enzymology
  • Cyclic GMP / metabolism
  • Drug Interactions
  • Guanylate Cyclase / drug effects
  • Guanylate Cyclase / metabolism*
  • Humans
  • In Vitro Techniques
  • Isatin / pharmacology*
  • Nitric Oxide / metabolism*
  • Nitric Oxide Donors / pharmacology*
  • Nitroprusside / pharmacology*

Substances

  • Nitric Oxide Donors
  • Nitroprusside
  • Nitric Oxide
  • Isatin
  • Guanylate Cyclase
  • Cyclic GMP